Atai Life Sciences N.V.

NasdaqGM:ATAI Stock Report

Market Cap: US$323.1m

Atai Life Sciences Dividend

Dividend criteria checks 0/6

Atai Life Sciences does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.4%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.24
Dividend yield forecast in 3Y0%

Recent dividend updates

No updates

Recent updates

Is Atai Life Sciences (NASDAQ:ATAI) Using Debt Sensibly?

Mar 02
Is Atai Life Sciences (NASDAQ:ATAI) Using Debt Sensibly?

atai Life Sciences achieves positive results in phase 1 trial of kratom-derived drug

Oct 12

Atai Life Sciences: Decentralized Drug Discovery Platform

Oct 06

ATAI Life Sciences GAAP EPS of -$0.24 misses by $0.01

Aug 15

We're Hopeful That Atai Life Sciences (NASDAQ:ATAI) Will Use Its Cash Wisely

Aug 07
We're Hopeful That Atai Life Sciences (NASDAQ:ATAI) Will Use Its Cash Wisely

Atai Life Sciences: Leading But Early Stage Psychedelic Therapeutics Developer

Jul 07

atai Life Sciences company Kures Therapeutics appoints Dr. Chad Beyer as CEO

Jun 30

Atai Life Sciences N.V.: A First Take

Jun 02

Atai Life Sciences And The Future Of Psychedelics For Mental Health

May 27

We're Hopeful That Atai Life Sciences (NASDAQ:ATAI) Will Use Its Cash Wisely

Apr 22
We're Hopeful That Atai Life Sciences (NASDAQ:ATAI) Will Use Its Cash Wisely

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if ATAI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ATAI's dividend payments have been increasing.


Dividend Yield vs Market

Atai Life Sciences Dividend Yield vs Market
How does ATAI dividend yield compare to the market?
SegmentDividend Yield
Company (ATAI)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.8%
Industry Average (Pharmaceuticals)2.4%
Analyst forecast in 3 Years (ATAI)0%

Notable Dividend: Unable to evaluate ATAI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ATAI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate ATAI's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ATAI has not reported any payouts.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.